Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025Carlyle (NA...
Stockholders that have previously tendered their shares must re-tender their sharesStockholders may elect to receive either $3....
Bluebird Bio revised its agreement with Carlyle and SK Capital, adding a $5 per share cash option for stockholders ahead of dea...
bluebird Board of Directors unanimously supports the transaction as the only viable option for stockholders to receive consider...
bluebird Board reaffirms unanimous recommendation in support of transaction with Carlyle and SK Capital and recommends all stoc...
BofA predicted a friendlier FTC under Trump. They were wrong. Deal activity was virtually flat in Q1. But it's a U.S. problem.
